Showing results (1-10 of 327) with videos related to
Sort By:
Pageof 33
Current Opinion in Virology|April 29, 2017
Therapeutic vaccination for chronic hepatitis BAnna D Kosinska, Tanja Bauer, Ulrike ProtzerBiomolecules|March 25, 2022
PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis BTill Bunse, Anna D Kosinska, Thomas Michler, et al.Digestive Diseases (Basel, Switzerland)|September 7, 2011
Immune control of hepatitis B virusTanja Bauer, Martin Sprinzl, Ulrike ProtzerMethods in Molecular Biology (Clifton, N.J.)|July 23, 2024
Production and Purification of Adeno-Associated Viral Vectors for the Development of Immune-Competent Mouse Models of Persistent Hepatitis B Virus ReplicationLisa Schiller, Chunkyu Ko, Anna D Kosinska, et al.Journal of Translational Medicine|June 20, 2020
Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial settingNina Körber, Uta Behrends, Ulrike Protzer, et al.Frontiers in Immunology|October 25, 2021
Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis BAlexandre Klopp, Sophia Schreiber, Anna D Kosinska, et al.Antiviral Research|July 20, 2021
Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectorsChunkyu Ko, Jinpeng Su, Julia Festag, et al.Journal of Translational Medicine|June 15, 2016
Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoringNina Körber, Uta Behrends, Alexander Hapfelmeier, et al.Microbial Biotechnology|October 1, 2011
Design of therapeutic vaccines: hepatitis B as an exampleSarah Kutscher, Tanja Bauer, Claudia Dembek, et al.Vaccines|August 28, 2021
Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV InfectionAnna D Kosinska, Julia Festag, Martin Mück-Häusl, et al.Pageof 33